{"id":"intradialytic-parenteral-nutrition","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Vascular access complications"},{"rate":null,"effect":"Infection at access site"},{"rate":null,"effect":"Electrolyte imbalances"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"IDPN is administered through the venous line of the dialysis circuit during treatment, allowing simultaneous delivery of macronutrients while waste removal occurs. This approach bypasses the gastrointestinal tract and provides concentrated nutrition to patients with inadequate oral intake or protein-energy wasting, a common complication of end-stage renal disease. The timing during dialysis optimizes nutrient delivery while minimizing additional vascular access requirements.","oneSentence":"Intradialytic parenteral nutrition (IDPN) delivers intravenous amino acids, dextrose, and lipids directly into the bloodstream during hemodialysis sessions to supplement nutritional intake in malnourished dialysis patients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:49:38.927Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Protein-energy wasting in hemodialysis patients with inadequate oral nutritional intake"},{"name":"Malnutrition in end-stage renal disease patients undergoing maintenance hemodialysis"}]},"trialDetails":[{"nctId":"NCT04094038","phase":"PHASE4","title":"The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2019-09-16","conditions":"End Stage Renal Disease, Malnutrition, Sarcopenia","enrollment":166},{"nctId":"NCT07254897","phase":"NA","title":"Long-term Muscle Synthetic Effects of Intradialytic Parenteral Nutrition in Chronic Hemodialysis Patients","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2026-01-01","conditions":"Malnutrition or Risk of Malnutrition","enrollment":16},{"nctId":"NCT06392516","phase":"NA","title":"Ketoacid Analogues Intradialytic Effect on Inflammation","status":"NOT_YET_RECRUITING","sponsor":"RSUP Fatmawati","startDate":"2024-04-29","conditions":"Hemodialysis Complication","enrollment":86},{"nctId":"NCT05439174","phase":"","title":"Impact of IDPN on Nutrition Markers in Patients Receiving ICHD","status":"UNKNOWN","sponsor":"Patient Care America","startDate":"2022-07-15","conditions":"End-stage Renal Disease, Malnutrition; Protein","enrollment":1200},{"nctId":"NCT04445558","phase":"NA","title":"Study of 2 Modalities of Dialysis and Nutrition on the Nutritional Status of Malnourished Chronic Renal Disease Patients","status":"COMPLETED","sponsor":"GCS Ramsay Santé pour l'Enseignement et la Recherche","startDate":"2020-07-21","conditions":"Renal Insufficiency","enrollment":11},{"nctId":"NCT03484481","phase":"","title":"Incomes of Nutritional Support Modalities in Hemodialysis Patients With Severe Malnutrition","status":"COMPLETED","sponsor":"Baskent University","startDate":"2016-01","conditions":"Severe Malnutrition","enrollment":56},{"nctId":"NCT00501956","phase":"PHASE4","title":"Intradialytic Parenteral Nutrition in Hemodialysis Patients","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2004-07","conditions":"Malnutrition, Complication of Hemodialysis","enrollment":140},{"nctId":"NCT01813851","phase":"NA","title":"Effect of Intradialytic Physical ACTIvity in Addition to a NUTritional Support on Protein Energy Wasting and Physical Functioning in Chronic Hemodialysis Patients (\"ACTINUT\" Study)","status":"TERMINATED","sponsor":"Nantes University Hospital","startDate":"2013-03","conditions":"Chronic Renal Failure, Hemodialysis Treatment, Protein-energy Wasting","enrollment":21},{"nctId":"NCT00314834","phase":"PHASE4","title":"Effect of Intradialytic Parenteral Nutrition on Morbidity and Mortality of Malnourished Hemodialysis Patients","status":"TERMINATED","sponsor":"EZUS-LYON 1","startDate":"2001-01","conditions":"Hemodialysis, Malnutrition","enrollment":204}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"HYPOTENSION"},{"count":1,"reaction":"LUNG NEOPLASM MALIGNANT"},{"count":1,"reaction":"NAUSEA"},{"count":1,"reaction":"PNEUMONIA"}],"_approvalHistory":[],"publicationCount":139,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Intradialytic parenteral nutrition","genericName":"Intradialytic parenteral nutrition","companyName":"EZUS-LYON 1","companyId":"ezus-lyon-1","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intradialytic parenteral nutrition (IDPN) delivers intravenous amino acids, dextrose, and lipids directly into the bloodstream during hemodialysis sessions to supplement nutritional intake in malnourished dialysis patients. Used for Protein-energy malnutrition in hemodialysis patients, Nutritional supplementation in end-stage renal disease patients unable to meet nutritional requirements orally.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}